iBio, Inc.
IBIO
$4.86
-$0.22-4.33%
| Weiss Ratings | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.60 | |||
| Price History | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.21% | |||
| 30-Day Total Return | 55.27% | |||
| 60-Day Total Return | 100.83% | |||
| 90-Day Total Return | 82.02% | |||
| Year to Date Total Return | 100.83% | |||
| 1-Year Total Return | 362.86% | |||
| 2-Year Total Return | -89.62% | |||
| 3-Year Total Return | -97.74% | |||
| 5-Year Total Return | -99.39% | |||
| 52-Week High % Change | -29.47% | |||
| 52-Week Low % Change | 362.86% | |||
| Price | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.89 | |||
| 52-Week Low Price | $1.05 | |||
| 52-Week Low Price (Date) | Mar 18, 2024 | |||
| 52-Week High Price (Date) | Mar 03, 2025 | |||
| Valuation | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 47.78M | |||
| Enterprise Value | 45.52M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.70 | |||
| Earnings Per Share Growth | -90.11% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 118.54 | |||
| Price/Book (Q) | 3.21 | |||
| Enterprise Value/Revenue (TTM) | 121.39 | |||
| Price | $4.86 | |||
| Enterprise Value/EBITDA (TTM) | -3.09 | |||
| Enterprise Value/EBIT | -2.93 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 9.13M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 979 446 0027 | |||
| Address | 11750 Sorrento Valley Road San Diego, CA 92121 | |||
| Website | ibioinc.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4,149.33% | |||
| Profit Margin | -5,147.46% | |||
| Management Effectiveness | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -34.91% | |||
| Return on Equity | -- | |||
| Income Statement | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 375.00K | |||
| Total Revenue (TTM) | 375.00K | |||
| Revenue Per Share | $0.04 | |||
| Gross Profit (TTM) | 375.00K | |||
| EBITDA (TTM) | -14.71M | |||
| EBIT (TTM) | -15.56M | |||
| Net Income (TTM) | -19.30M | |||
| Net Income Avl. to Common (TTM) | -19.30M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 2.76% | |||
| EPS Diluted (TTM) | -2.70 | |||
| EPS Diluted Growth (Q YOY) | 89.20% | |||
| Balance Sheet | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.02M | |||
| Cash Per Share (Q) | $0.77 | |||
| Total Current Assets (Q) | 8.29M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 13.90M | |||
| Current Ratio (Q) | 1.759 | |||
| Book Value Per Share (Q) | $1.52 | |||
| Total Assets (Q) | 21.70M | |||
| Total Current Liabilities (Q) | 4.71M | |||
| Total Debt (Q) | 4.75M | |||
| Total Liabilities (Q) | 7.80M | |||
| Total Common Equity (Q) | 13.90M | |||
| Cash Flow | IBIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.57M | |||
| Cash from Financing (TTM) | 17.70M | |||
| Net Change in Cash (TTM) | 3.18M | |||
| Levered Free Cash Flow (TTM) | 4.95M | |||
| Cash from Operations (TTM) | -16.09M | |||
